Laura McCullagh

Pharmacist. PhD. National Centre for Pharmacoeconomics, Ireland. Clinical Senior Lecturer, Trinity College Dublin. EC HTACG. Love Fermanagh. Views own.

[NCPE @INFO_NCPE]

‼️ We are moving to LinkedIn ‼️

You can find our LinkedIn account at https://t.co/CqWDnaDNNs

[Trinity College Dublin @tcddublin]

Three @TrinityMed1 researchers have been awarded
@hrbireland grants through the new Evidence for Policy Programme for patient-oriented research projects. Congratulations to Sara Burke, @IrinaKinchin
and Laura McCullagh! 👏🏻
More:https://t.co/DfV2eSrQbQ
#TrinityResearch

[Laura McCullagh @lauraontweets]

An exciting opportunity to work within a collaboration of experts @INFO_NCPE @IrishCancerReg @tilda_tcd and international experts. #ThisIsTrinityMed

[NCPE @INFO_NCPE]

‼️ Research Fellow Vacancy ‼️
We are looking for an experienced Research Fellow with a PhD in a related field of data analysis, statistics and /or epidemiology is sought for an exciting research project , collaborating with the NCPE, NCRI and TILDA(1/2)

[Caroline Walsh @CarolineWah25]

@lauraontweets @leatl4 @adamsncpe @CHeDS_ie

[NCPE @INFO_NCPE]

🌟We are still accepting applications for three health technology assessors and a senior health technology assessor until October 28th! 🌟

[NCPE @INFO_NCPE]

Would you be interested in applying for the role of Health Technology Assessor or Senior Health Technology Assessor at the NCPE? We are accepting applications until the 28th of October at https://t.co/F8NEk9g1fq

[NCPE @INFO_NCPE]

The NCPE are seeking input from Patient Organisations for our appraisal of Ivosidenib (Tibsovo), for patients with newly diagnosed acute myeloid leukaemia, with an IDH1 R132 mutation, who are not eligible to receive standard induction chemotherapy. See: https://t.co/JrSiPSLPmK)

[NCPE @INFO_NCPE]

The NCPE is hiring! Would you be interested in applying for the role of Health Technology Assessor at the NCPE?

The NCPE is building capacity to develop our national assessment work, European HTA collaborations and national HTA policy. Apply at: https://t.co/cE9X9ddQRB

[Laura McCullagh @lauraontweets]

@shikhasharma06 (@INFO_NCPE and @TCDTMI) presenting some of her research for the #HEALED Consortium at the @CancerInstIRE research day. @DisruptiveEI #ThisIsTrinityMed #TILtherapies

[NCPE @INFO_NCPE]

🔔 Our Annual Symposium Schedule has been finalised! 🔔
The NCPE Annual Symposium will be held on Thursday 10th October 2024 in Dublin Castle. Registration is available at https://t.co/8mfLxSezr2

[NCPE @INFO_NCPE]

The NCPE are seeking input from Patient Organisations for our appraisal of zanubrutinib (Brukinsa) monotherapy for adult patients with relapsed/refractory marginal zone lymphoma with at least one prior anti-CD20-based therapy. More details at  (https://t.co/JrSiPSLPmK)

[Laura McCullagh @lauraontweets]

Well done @shikhasharma06 for leading this useful reaserch for #HEALED. #ThisIsTrinityMed

[NCPE @INFO_NCPE]

Great to see that research led by @shikhasharma06 (@INFO_NCPE and HEALED consortium) “Systematic review of economic evaluations of systemic treatments for second or later line treatment for advanced and metastatic gastric cancer” published (https://t.co/M6AnIossDV) (1/2)

[NCPE @INFO_NCPE]

Great to see that research led by @shikhasharma06 (@INFO_NCPE and HEALED consortium) “Systematic review of economic evaluations of systemic treatments for second or later line treatment for advanced and metastatic gastric cancer” published (https://t.co/M6AnIossDV) (1/2)

[NCPE @INFO_NCPE]

We are accepting applications until this Sunday the 30th of June!

[NCPE @INFO_NCPE]

The NCPE is recruiting! We are expanding our team to build capacity for significant EU and national developments in HTA! If you would be interested in applying for a HTA assessor or statistician role, further information can be found at: https://t.co/tgvI25cO5Q

[NCPE @INFO_NCPE]

The NCPE are seeking input from Patient Organisations for our appraisal of tezepelumab (Tezspire®) as add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma, who are inadequately controlled despite high-dose inhaled corticosteroids (1/2)

[NCPE @INFO_NCPE]

The NCPE are seeking input from Patient Organisations for our appraisal of anifrolumab (Saphnelo®) as an add-on for adult patients with moderate/severe, active autoantibody-positive systemic lupus erythematosus, despite standard therapy. More details at (https://t.co/JrSiPSLhxc)

[NCPE @INFO_NCPE]

Heather Eames presented on how semi automated horizon scanning can complement national horizon scanning processes. This research was made possible by the NCPE’s membership in the international horizon scanning initiative. More info on IHSI is available at: https://t.co/Iy1wYCyUcz

[NCPE @INFO_NCPE]

Our head of strategy, Dr Roisin Adams, is talking now at the opening plenary this morning at HTAi #htai2024